Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametin...

Date 28 September 2015
Event European Cancer Congress 2015
Session Melanoma and Skin Cancer II
Topics Melanoma and other Skin Tumours
Presenter Robert, C.